Literature DB >> 16327328

Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis.

Guillaume Breton1, Homa Adle-Biassette, Audrey Therby, Jacky Ramanoelina, Laurence Choudat, François Bissuel, Michel Huerre, Françoise Dromer, Bertrand Dupont, Olivier Lortholary.   

Abstract

Four HIV-1-infected patients presented with unusual clinical manifestations in the course of disseminated histoplasmosis, including liver abscesses, compressive lymphadenitis, intestinal obstruction, uveitis and arthritis within a median of 45 days after initiation of highly active antiretroviral therapy (HAART). They had a median increase of 106 CD4 cells/mul and granulomas with caseation in three. Partial immune reconstitution induced by HAART during disseminated histoplasmosis either related to the variety capsulatum or duboisii may be associated with immune reconstitution inflammatory syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16327328     DOI: 10.1097/01.aids.0000199014.66139.39

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

1.  Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras.

Authors:  Vincent Peigne; Françoise Dromer; Caroline Elie; Olivier Lidove; Olivier Lortholary
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 2.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

Review 3.  Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses.

Authors:  N Singh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

Review 4.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Authors:  Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack Sobel; Claudio Viscoli; Thomas J Walsh; Johan Maertens; Thomas F Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John R Graybill; Lindsey R Baden; Peter G Pappas; John E Bennett; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart-Jan Kullberg; William E Dismukes; Ben E De Pauw
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

5.  Diagnosing Ring-Enhancing Lesions in the Brain of a Patient With AIDS Without Brain Biopsy: A Case of Central Nervous System Histoplasmoma.

Authors:  Rachel Beekman; Jessica M Hu; Steven I Aronin; Maricar F Malinis
Journal:  Neurohospitalist       Date:  2017-10-02

Review 6.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Unmasking leprosy: an unusual immune reconstitution inflammatory syndrome in a patient infected with human immunodeficiency virus.

Authors:  Guillaume Bussone; Caroline Charlier; Emmanuelle Bille; Frédéric Caux; Annie Lévy; Jean-Paul Viard; Marc Lecuit; Olivier Lortholary
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 8.  Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none.

Authors:  Daniel L Barber; Bruno B Andrade; Irini Sereti; Alan Sher
Journal:  Nat Rev Microbiol       Date:  2012-01-09       Impact factor: 60.633

Review 9.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

10.  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study.

Authors:  Juan G Sierra-Madero; Susan Ellenberg; Mohammed S Rassool; Ann Tierney; Pablo F Belaunzarán-Zamudio; Alondra López-Martínez; Alicia Piñeirúa-Menéndez; Luis J Montaner; Livio Azzoni; César Rivera Benítez; Irini Sereti; Jaime Andrade-Villanueva; Juan L Mosqueda-Gómez; Benigno Rodriguez; Ian Sanne; Michael M Lederman
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.